Загрузка...
A Novel Recombinant Fcγ Receptor-Targeted Survivin Combines with Chemotherapy for Efficient Cancer Treatment
Formyl peptide receptor-like 1 inhibitor (FLIPr), an Fcγ receptor (FcγR) antagonist, can be used as a carrier to guide antigen-FLIPr fusion protein to FcγR then enhances antigen-specific immune responses. Survivin, a tumor-associated antigen, is over-expressed in various types of human cancer. In th...
Сохранить в:
| Опубликовано в: : | Biomedicines |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8301409/ https://ncbi.nlm.nih.gov/pubmed/34356870 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines9070806 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|